Fingerprint
Dive into the research topics of '18F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
18F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer
Ronald L. Korn, Daniel D. Von Hoff, Mitesh J. Borad, Markus F. Renschler, Desmond McGovern, R. Curtis Bay, Ramesh K. Ramanathan
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations